Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jill, McCollam"'
Autor:
Natasha Atanaskova Mesinkovska, Brett A. King, Sergio Vañó‐Galván, Yutaka Shimomura, Jakub Jedynak, Jill McCollam, Evangeline Pierce, Amy K. Ellinwood, Rodney Sinclair
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 528-535 (2024)
Abstract Background The Severity of Alopecia Tool (SALT) is a standardized method for quantifying scalp hair loss in alopecia areata (AA). SALT scores can be used to guide treatment decisions and are widely used as eligibility criteria and endpoints
Externí odkaz:
https://doaj.org/article/10df0df3e50e45c29038a20cd9d1845a
Autor:
Ohsang Kwon, Maryanne M. Senna, Rodney Sinclair, Taisuke Ito, Yves Dutronc, Chen-Yen Lin, Guanglei Yu, Chiara Chiasserini, Jill McCollam, Wen-Shuo Wu, Brett King
Publikováno v:
American Journal of Clinical Dermatology. 24:443-451
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::277e575eac0f5f3459c0f1a1a5781657
https://doi.org/10.1007/s40257-023-00764-w
https://doi.org/10.1007/s40257-023-00764-w
Autor:
Brett King, Arash Mostaghimi, Yutaka Shimomura, Abraham Zlotogorski, Gwang-Seong Choi, Ulrike Blume-Peytavi, Thierry Passeron, Katrin Holzwarth, Yves Dutronc, Jill McCollam, Fan Emily Yang, Sarah Stanley, Wen-Shuo Wu, Rodney Sinclair
Publikováno v:
British Journal of Dermatology. 188:218-227
Background Baricitinib, an oral, selective, reversible Janus kinase (JAK)1/JAK2 inhibitor, is an approved treatment for adults with severe alopecia areata (AA) in the USA, European Union and Japan. Objectives To report safety data for baricitinib in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bacb22708073ac4764585645bafb8fa
https://doi.org/10.1093/bjd/ljac059
https://doi.org/10.1093/bjd/ljac059
Autor:
Brett, King, Manabu, Ohyama, Ohsang, Kwon, Abraham, Zlotogorski, Justin, Ko, Natasha A, Mesinkovska, Maria, Hordinsky, Yves, Dutronc, Wen-Shuo, Wu, Jill, McCollam, Chiara, Chiasserini, Guanglei, Yu, Sarah, Stanley, Katrin, Holzwarth, Amy M, DeLozier, Rodney, Sinclair, Matthew, Zirwas
Publikováno v:
The New England journal of medicine. 386(18)
Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are limited. Baricitinib, an oral, selective, reversible inhibitor of Janus kinases 1 and 2, may interrupt cytokin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c835e83b3bf5f0047cf3f976d1ff3e
https://pubmed.ncbi.nlm.nih.gov/35507486
https://pubmed.ncbi.nlm.nih.gov/35507486